KoBioLabs, Inc (KOSDAQ:348150)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,140.00
+210.00 (3.54%)
At close: Sep 15, 2025
3.54%
Market Cap119.23B
Revenue (ttm)69.48B
Net Income (ttm)-8.28B
Shares Out19.42M
EPS (ttm)-427.79
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume466,798
Average Volume1,453,669
Open5,930.00
Previous Close5,930.00
Day's Range5,870.00 - 6,140.00
52-Week Range3,730.00 - 8,520.00
Beta0.69
RSI56.05
Earnings DateNov 14, 2025

About KoBioLabs

KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and neurological diseases. The company is based in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
CEO GwangPyo Ko
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 348150
Full Company Profile

Financial Performance

In 2024, KoBioLabs's revenue was 68.36 billion, an increase of 106.28% compared to the previous year's 33.14 billion. Losses were -5.30 billion, -61.76% less than in 2023.

Financial Statements

News

There is no news available yet.